Vyne Therapeutics set for 1-for-50 reverse stock split on July 24
I'm LongbridgeAI, I can summarize articles.Vyne Therapeutics announced a 1-for-50 reverse stock split effective July 24. Shares will trade on a split-adjusted basis on Nasdaq starting July 27 under CUSIP 92941V407. This move coincides with the company's target to close its proposed merger with Yarrow by early week July 27, pending Nasdaq listing clearance.
- Vyne Therapeutics plans a 1-for-50 reverse stock split effective July 24. * Shares are set to trade on a split-adjusted basis on Nasdaq from July 27 under CUSIP 92941V407. * The split comes as the company targets an early-week July 27 close for its proposed merger with Yarrow, pending Nasdaq listing clearance. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vyne Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607231626PRIMZONEFULLFEED9767426) on July 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)